SPAC222.13c Antibody

What approaches are most effective for developing antibodies against S. pombe proteins like SPAC222.13c?

Custom antibody development for S. pombe proteins typically follows a strategic approach similar to that used for Psk1 antibodies, where synthetic peptides representing unique epitopes of the target protein are used as immunogens. For optimal results, select peptide sequences with high antigenicity scores while avoiding regions that share homology with other S. pombe proteins. The antibody production process includes multiple immunization steps in rabbits with purified peptide conjugated to carrier proteins, followed by affinity purification against the immunizing peptide . This approach yields highly specific antibodies that can recognize both native and denatured forms of the target protein, essential for techniques like Western blotting and immunoprecipitation.

How can I validate the specificity of a SPAC222.13c antibody?

Validation of SPAC222.13c antibodies requires a multi-faceted approach to ensure specificity. First, perform Western blot analysis comparing wild-type strains with deletion mutants (ΔSPAC222.13c) to verify absence of signal in the knockout strain. Second, conduct immunoprecipitation experiments followed by mass spectrometry analysis to confirm the antibody pulls down the target protein and its interacting partners. This approach was effectively demonstrated in studies of Gtr1-Gtr2 heterodimer complexes where co-purified proteins were identified through successive immunoprecipitation procedures . Finally, protein expression patterns detected by the antibody should correlate with mRNA expression data from RT-PCR analysis, particularly in meiotic cells where many S. pombe proteins show specific expression patterns .

What are the key considerations when planning immunoprecipitation experiments with SPAC222.13c antibodies?

Successful immunoprecipitation with SPAC222.13c antibodies requires careful optimization of lysis conditions to maintain protein stability and native interactions. Based on established protocols for S. pombe proteins, cells should be disrupted in a buffer containing 20 mM HEPES-KOH (pH 7.5), 150 mM potassium glutamate, 10% glycerol, and 0.25% Tween-20, supplemented with phosphatase inhibitors (10 mM sodium fluoride, 10 mM p-nitrophenylphosphate, 10 mM sodium pyrophosphate, 10 mM β-glycerophosphate, and 0.1 mM sodium orthovanadate) and protease inhibitors (PMSF, leupeptin, and protease inhibitor cocktail) . For antibody coupling, magnetic beads offer advantages over agarose-based matrices for reduced background and higher sensitivity. Serial immunoprecipitation may be necessary when studying protein complexes, as demonstrated in the purification of Gtr1-Gtr2 heterodimer complexes where successive immunoprecipitation with different epitope tags enabled isolation of specific protein complexes .

How can SPAC222.13c antibodies be used in comparative proteome analysis of S. pombe?

SPAC222.13c antibodies serve as valuable tools in comparative proteome analysis, enabling the investigation of protein expression levels across different experimental conditions. Following the methodology used for proteome analysis in S. pombe strains with varying protein production levels, researchers can employ antibodies in a Western blot validation strategy complementary to mass spectrometry-based quantification . For comprehensive analysis, implement an isobaric labeling approach using iTRAQ reagents for peptide labeling, followed by two-dimensional LC-MALDI MS for protein identification and quantification. This technique allows detection of complex changes in protein expression patterns, from chaperones and secretory transport machinery to proteins controlling transcription and translation . SPAC222.13c antibodies can validate mass spectrometry findings for specific proteins, providing orthogonal confirmation of expression changes observed in the global proteome analysis.

What protocols exist for studying protein localization using SPAC222.13c antibodies in fluorescence microscopy?

For subcellular localization studies of SPAC222.13c proteins, immunofluorescence microscopy using specific antibodies follows established S. pombe protocols. Cells grown exponentially in EMM liquid medium should be fixed with either formaldehyde or methanol depending on epitope accessibility. For optimal visualization, acquire Z-axial images at 0.4 μm intervals using a 100X objective lens and perform deconvolution to enhance signal-to-noise ratio . Co-localization with organelle markers, such as FM4-64 for vacuole visualization, provides contextual information about protein distribution. For quantitative analysis, examine at least 200 cells per condition to account for cell-to-cell variability . When designing multi-color immunofluorescence experiments, careful selection of fluorophore-conjugated secondary antibodies with minimal spectral overlap is essential to avoid bleed-through artifacts.

How can I optimize Western blot protocols for detecting SPAC222.13c protein in S. pombe lysates?

Western blot optimization for SPAC222.13c detection requires careful consideration of sample preparation, electrophoresis conditions, and detection parameters. For sample preparation, harvest cells in 10% trichloroacetic acid (TCA) to effectively precipitate proteins and inactivate proteases, followed by mechanical disruption with glass beads . Determine protein concentration using the Bio-Rad protein assay kit to ensure consistent loading across samples. For SDS-PAGE, 12% polyacrylamide gels provide optimal resolution for most S. pombe proteins, though gradient gels (4-20%) may be preferable for detecting post-translational modifications that affect mobility. During transfer to nitrocellulose membranes, use a wet transfer system with 20% methanol for standard-sized proteins or reduce methanol concentration for larger proteins. For antibody incubation, a 1:1000 to 1:5000 dilution range typically provides optimal signal-to-noise ratio, though this must be empirically determined for each antibody batch .

What approaches can I use to study SPAC222.13c interactions within protein complexes?

To investigate SPAC222.13c interactions within protein complexes, implement a multi-method approach combining co-immunoprecipitation, mass spectrometry, and functional assays. First, perform co-immunoprecipitation experiments using SPAC222.13c antibodies coupled to magnetic beads, followed by mass spectrometry identification of co-purified proteins. This approach successfully identified novel protein complexes in S. pombe, such as the Lam1-Lam4 complex that interacts with Gtr1-Gtr2 GTPases . For validation of direct protein interactions, perform reciprocal co-immunoprecipitation experiments and affinity pull-down assays with purified recombinant proteins. To assess the functional significance of identified interactions, conduct genetic analysis using deletion mutants and overexpression strains to identify synthetic lethality or suppression relationships. Complementary approaches such as yeast two-hybrid assays or proximity labeling methods can provide additional evidence for protein interactions in vivo.

How can I determine if SPAC222.13c forms complexes similar to known protein families in S. pombe?

To determine if SPAC222.13c forms complexes similar to known protein families, implement a comparative analysis approach that integrates structural predictions, sequence homology, and experimental data. Begin with bioinformatic analysis using secondary structure prediction tools to identify structural motifs similar to those found in characterized protein complexes, such as the roadblock domain identified in Ragulator components . Next, perform co-immunoprecipitation experiments with SPAC222.13c antibodies followed by mass spectrometry to identify interacting partners. Compare the composition of this complex with known protein families by examining shared components, similar stoichiometry, or conserved interaction patterns. For functional characterization, assess whether the SPAC222.13c complex responds to the same stimuli or localizes to similar subcellular compartments as known complexes. This integrated approach has successfully identified novel protein complexes in S. pombe that are functionally similar to mammalian counterparts despite limited sequence conservation .

What techniques are available for studying dynamic changes in SPAC222.13c complexes during cellular processes?

For studying dynamic changes in SPAC222.13c complexes during cellular processes, implement time-course experiments combined with quantitative proteomics and functional assays. Begin by synchronizing cells using established methods for S. pombe, such as nitrogen starvation followed by release or temperature-sensitive cell cycle mutants. At defined time points, perform immunoprecipitation with SPAC222.13c antibodies followed by mass spectrometry analysis with isobaric labeling (iTRAQ) for quantitative comparison of complex composition across time points . This approach allows detection of transient interactions and stoichiometric changes in response to cellular signals. To correlate complex dynamics with functional outcomes, simultaneously monitor relevant cellular processes using appropriate assays. For instance, when studying meiotic processes, collect cells at 2-hour intervals after meiotic induction for Western blot analysis of SPAC222.13c and known meiotic markers . Complementary approaches including live-cell imaging with fluorescently tagged proteins can provide real-time visualization of complex dynamics.

What mass spectrometry protocols are optimal for analyzing immunoprecipitated SPAC222.13c and its interacting partners?

For optimal mass spectrometric analysis of immunoprecipitated SPAC222.13c and its interacting partners, implement a comprehensive workflow beginning with efficient sample preparation. After immunoprecipitation, resolve protein complexes on a 12% Mini-PROTEAN TGX precast gel, divide each lane into multiple pieces, and perform in-gel digestion with trypsin . For mass spectrometry analysis, utilize an LTQ-Orbitrap XL-HTC-PAL system, which provides high resolution and mass accuracy for confident protein identification. Process MS/MS spectra using Mascot server and compare against the NCBInr protein database with taxonomy restricted to S. pombe . For quantitative analysis, implement isobaric labeling strategies such as iTRAQ, where peptides from different samples are labeled with isotopically distinct tags (e.g., iTRAQ tags 114, 115, 116, and 117) before pooling for LC-MS/MS analysis . This approach enables relative quantification of proteins across multiple samples in a single MS run. For complex samples, employ two-dimensional liquid chromatography separation prior to MS analysis to increase proteome coverage and identification of low-abundance interacting partners.

How can I generate recombinant SPAC222.13c protein for antibody production and interaction studies?

Production of recombinant SPAC222.13c protein follows a systematic approach similar to established protocols for S. pombe proteins. Begin by amplifying the SPAC222.13c cDNA by RT-PCR from S. pombe mRNA using primers with appropriate restriction sites (e.g., NdeI and BamHI) . Clone the PCR product into expression vectors such as pET16b or pET28b, which add histidine tags for purification purposes. For protein expression, transform E. coli BL21(DE3) RP cells with the expression plasmid, and induce protein synthesis with 0.1 mM IPTG at OD600 = 0.4 . Harvest cells after 4 hours of induction at 30°C.

For protein purification, resuspend cell paste in P5 buffer (50 mM sodium phosphate pH 7.0, 500 mM NaCl, 10% glycerol, 0.02% Triton X-100) containing 5 mM imidazole and protease inhibitors, then sonicate to lyse cells . Remove insoluble material by centrifugation and purify the soluble fraction using nickel affinity chromatography. If the protein exhibits poor solubility when expressed alone, co-express with potential binding partners, as demonstrated for spHop2 and spMnd1 proteins which were only soluble when co-expressed . For interaction studies, use the purified recombinant protein in in vitro binding assays, such as affinity pull-downs with covalently bound potential interacting partners on NHS-activated Sepharose .

What are the considerations for cross-species reactivity when using antibodies against SPAC222.13c homologs?

When evaluating cross-species reactivity of antibodies against SPAC222.13c homologs, several critical factors must be considered. First, perform sequence alignment analysis to assess conservation of the epitope region across species. The degree of sequence identity in the immunizing peptide region correlates strongly with cross-reactivity potential. For example, antibodies raised against mouse Hop2 successfully cross-recognized the S. pombe homolog due to conserved epitopes . Second, validate cross-reactivity experimentally through Western blot analysis using protein extracts from multiple species, assessing both signal intensity and specificity by comparing wild-type and knockout controls where available.

Third, consider structural conservation beyond primary sequence, as conformational epitopes may be preserved despite sequence divergence. Fourth, when designing antibodies intended for cross-species applications, target highly conserved domains or peptides identified through multiple sequence alignments. Finally, optimize immunodetection conditions for each species independently, as parameters such as blocking agents, antibody concentration, and incubation times may require adjustment to maximize signal-to-noise ratio in different species contexts. These considerations ensure reliable interpretation of results when using antibodies across evolutionary boundaries in comparative studies.

What are common challenges in immunoprecipitation experiments with SPAC222.13c antibodies and how can they be addressed?

Immunoprecipitation with SPAC222.13c antibodies may encounter several technical challenges that require systematic troubleshooting. One common issue is low precipitation efficiency, which can be addressed by optimizing antibody concentration, incubation time (1.5-2 hours at 4°C is typically optimal), and coupling method to beads . Another challenge is high background or non-specific binding, which can be minimized by using more stringent washing conditions (increasing salt concentration in wash buffers) or pre-clearing lysates with beads alone before immunoprecipitation.

For complex stability issues, adjust lysis buffer composition to maintain native interactions—for example, replacing NaCl with potassium glutamate may preserve certain protein complexes more effectively, as demonstrated in protocols for S. pombe protein complex purification . When specific interactions appear inconsistent, consider protein expression levels and cell cycle regulation; for meiosis-specific interactions, collect cells at appropriate timepoints after meiotic induction . Finally, to enhance detection of transient or weak interactions, consider using crosslinking agents before cell lysis or employing proximity-dependent labeling approaches as alternatives to conventional immunoprecipitation.

How can I quantitatively assess the quality and specificity of a SPAC222.13c antibody lot?

Quantitative assessment of SPAC222.13c antibody quality requires a comprehensive validation strategy. Begin with Western blot analysis using recombinant SPAC222.13c protein at known concentrations (1-100 ng) to generate a standard curve for determining antibody sensitivity. Calculate the limit of detection and linear dynamic range to establish quantitative parameters for experimental applications. Next, assess specificity through competitive binding assays by pre-incubating the antibody with increasing concentrations of immunizing peptide before Western blot or immunoprecipitation, expecting signal reduction proportional to peptide concentration.

For cross-reactivity assessment, perform Western blots against total protein extracts from wild-type and ΔSPAC222.13c deletion strains, calculating the signal ratio between specific and non-specific bands as a specificity index. Additionally, evaluate lot-to-lot consistency by comparing multiple antibody preparations against the same samples, calculating coefficient of variation values below 15% for acceptable reproducibility. Finally, for functional validation, perform immunoprecipitation followed by mass spectrometry, assessing the percentage of immunoprecipitated protein that corresponds to SPAC222.13c and known interacting partners versus non-specific proteins .

What controls are essential when designing experiments with SPAC222.13c antibodies?

Rigorous experimental design with SPAC222.13c antibodies requires implementation of multiple control types. First, inclusion of genetic controls—comparing wild-type strains with ΔSPAC222.13c deletion mutants—provides definitive validation of antibody specificity. Second, technical controls should include isotype-matched irrelevant antibodies for immunoprecipitation and immunofluorescence experiments to distinguish specific binding from Fc receptor interactions or other non-specific effects.

Third, peptide competition controls, where the antibody is pre-incubated with the immunizing peptide, confirm epitope-specific binding. Fourth, loading controls are essential for quantitative Western blot analysis, with anti-Spc1 being a widely used standard in S. pombe studies . Fifth, when studying protein complexes, verify interactions through reciprocal immunoprecipitation with antibodies against suspected binding partners. Finally, for immunofluorescence studies, include appropriate subcellular markers and single-fluorophore controls to ensure accurate interpretation of localization patterns. This comprehensive control strategy ensures reliable and reproducible results when working with SPAC222.13c antibodies across different experimental applications.

How should I interpret changes in SPAC222.13c protein levels detected by antibodies in proteome analysis?

Interpretation of SPAC222.13c protein level changes requires contextual analysis within the broader cellular response. When analyzing proteomics data, first normalize SPAC222.13c expression changes relative to housekeeping proteins to account for technical variability. Then, evaluate statistical significance using appropriate methods—for iTRAQ-based quantification, apply FDR-corrected p-values with a threshold typically set at p<0.05 and fold-change cutoffs of 1.5-2.0 . Next, examine co-regulated proteins within the same biological pathway or complex to identify coordinated responses. For example, in studies of protein production burden in S. pombe, observed changes in various cellular components from chaperones to metabolic enzymes reflected systematic adaptation .

Compare protein-level changes with transcriptional data where available to distinguish between transcriptional and post-transcriptional regulation. For functional interpretation, consider how SPAC222.13c level changes correlate with specific cellular processes or stress responses. Finally, validate key findings through orthogonal techniques such as targeted Western blotting with the SPAC222.13c antibody, which provides an independent measurement method to confirm mass spectrometry-based quantification .

What bioinformatics approaches are useful for analyzing SPAC222.13c interaction networks from immunoprecipitation-mass spectrometry data?

For comprehensive analysis of SPAC222.13c interaction networks from immunoprecipitation-mass spectrometry data, implement a multi-layered bioinformatics workflow. Begin with statistical filtering to identify high-confidence interactors, applying scoring algorithms that incorporate parameters such as peptide count, sequence coverage, and enrichment ratio compared to control immunoprecipitations. For quantitative analysis of complex composition across conditions, utilize visualization tools like heat maps or volcano plots to highlight significantly changing interactions.

Next, perform functional enrichment analysis using Gene Ontology terms to identify biological processes overrepresented among SPAC222.13c interactors. Integrate this data with known protein-protein interaction databases specific to S. pombe to place novel interactions in context of established networks. For structural insights, apply domain-based interaction prediction to identify potential binding interfaces between SPAC222.13c and its partners, similar to the roadblock domain analysis used for Ragulator components .

Finally, implement comparative interactomics by comparing the SPAC222.13c interaction network with homologous proteins in other species to identify evolutionarily conserved complexes. This approach successfully identified functional counterparts between fission yeast and mammalian protein complexes despite limited sequence conservation .

How can I integrate antibody-based detection of SPAC222.13c with other -omics approaches?

Integration of antibody-based SPAC222.13c detection with other -omics approaches creates a comprehensive multi-layered analysis of protein function. First, combine antibody-based quantification of SPAC222.13c protein levels with transcriptomics data to calculate protein-to-mRNA ratios, revealing post-transcriptional regulation mechanisms. This approach can identify conditions where protein levels change independently of mRNA abundance, suggesting regulation at the translational or post-translational level.

Second, correlate SPAC222.13c localization data from immunofluorescence with spatial proteomics datasets to understand compartment-specific functions and regulation. Third, integrate immunoprecipitation-mass spectrometry data with phosphoproteomics to identify phosphorylation-dependent interactions, revealing dynamic regulation of SPAC222.13c complexes in response to cellular signals.

Fourth, combine metabolomics data with SPAC222.13c protein levels to identify correlations between protein expression and metabolic changes, similar to the observed relationship between protein production burden and central carbon metabolism in S. pombe . Finally, implement network analysis algorithms to integrate these multi-omics datasets, constructing predictive models of SPAC222.13c function within cellular signaling networks. This integrated approach provides mechanistic insights beyond what can be achieved with any single methodology.

Methodological Comparison Table

How can SPAC222.13c antibodies be used to study protein dynamics during cellular stress responses?

SPAC222.13c antibodies enable detailed investigation of protein dynamics during cellular stress responses through time-course analyses with multiple detection methods. Begin by exposing S. pombe cultures to relevant stressors (oxidative stress, nutrient limitation, or temperature shifts) and collecting samples at defined intervals. Perform Western blot analysis with SPAC222.13c antibodies to track expression level changes, complemented by subcellular fractionation to monitor potential relocalization between compartments. For higher temporal resolution, implement pulse-chase experiments with metabolic labeling followed by immunoprecipitation to measure protein synthesis and degradation rates under stress conditions.

To understand how stress affects SPAC222.13c interactions, perform co-immunoprecipitation at each timepoint followed by mass spectrometry, using isobaric labeling for quantitative comparison across the time course . This approach reveals dynamic changes in complex composition during stress adaptation. Correlate these molecular data with physiological responses, similar to how changes in protein secretion were linked to amino acid metabolism in S. pombe under production stress . Finally, perform genetic epistasis experiments with stress response pathway mutants to position SPAC222.13c functionally within cellular stress response networks.

What considerations are important when designing CRISPR-based genome editing experiments verified with SPAC222.13c antibodies?

When designing CRISPR-based genome editing experiments for SPAC222.13c, implement a comprehensive validation strategy using specific antibodies. First, for guide RNA design, select target sequences with minimal off-target potential in the S. pombe genome, preferably targeting functional domains while avoiding epitope regions recognized by the validation antibody. After transformation and selection, perform PCR-based genotyping followed by sequencing to confirm the intended modification at the genomic level.

For protein-level validation, Western blot analysis with SPAC222.13c antibodies provides essential confirmation of knockout efficiency, domain deletion, or tag insertion. When introducing point mutations, demonstrate both the presence of the protein (albeit modified) and the functional consequence through appropriate assays. For knock-in of fluorescent tags, verify correct localization by comparing immunofluorescence using SPAC222.13c antibodies with the direct fluorescence signal.